GTLS:NYSEChart Industries, Inc. Analysis
Data as of 2026-04-07 - not real-time
$207.57
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Chart Industries is trading near its short‑term resistance with a neutral technical outlook. The price sits just above its 20‑day and 50‑day moving averages, the Relative Strength Index is in the upper‑mid range, and the MACD has turned bullish, yet trading volume is on a downtrend, suggesting limited upside momentum.
Fundamentally, the stock appears dramatically overvalued: the price‑to‑earnings multiple is astronomically higher than the sector average and a discounted cash‑flow model values the company at a fraction of the current price. Earnings growth expectations are high, as reflected by a strong forward earnings estimate, but recent quarter results missed revenue expectations and the company is experiencing a modest decline in sales. With a high debt load, thin profit margins and no dividend, the upside is constrained unless a clear catalyst materializes in its LNG or hydrogen businesses.
Fundamentally, the stock appears dramatically overvalued: the price‑to‑earnings multiple is astronomically higher than the sector average and a discounted cash‑flow model values the company at a fraction of the current price. Earnings growth expectations are high, as reflected by a strong forward earnings estimate, but recent quarter results missed revenue expectations and the company is experiencing a modest decline in sales. With a high debt load, thin profit margins and no dividend, the upside is constrained unless a clear catalyst materializes in its LNG or hydrogen businesses.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price at short‑term resistance with weakening volume
- Recent earnings miss and revenue decline
- Technical indicators showing limited momentum
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- High forward earnings expectations versus current valuation gap
- Exposure to growing LNG and hydrogen markets
- Elevated debt levels and thin profit margins
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental overvaluation relative to cash‑flow based fair value
- Lack of dividend and high leverage limiting downside protection
- Uncertainty around sustained earnings growth without clear catalysts
Key Metrics & Analysis
Financial Health
Revenue Growth-2.50%
Profit Margin0.95%
P/E Ratio629.0
ROE1.22%
ROA4.27%
Debt/Equity109.01
P/B Ratio3.1
Op. Cash Flow$292.7M
Free Cash Flow$393.9M
Industry P/E29.7
Technical Analysis
TrendNeutral
RSI60.4
Support$206.25
Resistance$207.57
MA 20$207.03
MA 50$207.14
MA 200$198.05
MACDBullish
VolumeDecreasing
Fear & Greed Index76.66
Valuation
Fair Value$41.24
Target Price$205.67
Upside/Downside-0.92%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.09
Volatility1.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.